At the end of the latest market close, TherapeuticsMD Inc. (TXMD) was valued at $1.68. In that particular session, Stock kicked-off at the price of $1.69 while reaching the peak value of $1.81 and lowest value recorded on the day was $1.69. The stock current value is $1.76.
Recently in News on September 25, 2020, TherapeuticsMD Provides Update on Third Quarter Progress. -Company believes industry prescription tracking databases are not accurately tracking ANNOVERA®-. You can read further details here
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
TherapeuticsMD Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.9300 on 01/22/20, with the lowest value was $0.8530 for the same time period, recorded on 04/15/20.
TherapeuticsMD Inc. (TXMD) full year performance was -52.17%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, TherapeuticsMD Inc. shares are logging -56.00% during the 52-week period from high price, and 106.33% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.85 and $4.00.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2996056 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the TherapeuticsMD Inc. (TXMD) recorded performance in the market was -27.27%, having the revenues showcasing 17.33% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 497.34M, as it employees total of 348 workers.
TherapeuticsMD Inc. (TXMD) in the eye of market guru’s
During the last month, 7 analysts gave the TherapeuticsMD Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.4868, with a change in the price was noted +0.5700. In a similar fashion, TherapeuticsMD Inc. posted a movement of +47.90% for the period of last 100 days, recording 4,353,268 in trading volumes.
TherapeuticsMD Inc. (TXMD): Stocks Technical analysis and Trends
Raw Stochastic average of TherapeuticsMD Inc. in the period of last 50 days is set at 58.23%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 90.20%. In the last 20 days, the company’s Stochastic %K was 86.73% and its Stochastic %D was recorded 83.33%.
If we look into the earlier routines of TherapeuticsMD Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -27.27%. Additionally, trading for the stock in the period of the last six months notably improved by 72.55%, alongside a downfall of -52.17% for the period of the last 12 months. The shares increased approximately by 6.67% in the 7-day charts and went down by 31.34% in the period of the last 30 days. Common stock shares were driven by 17.33% during last recorded quarter.